Does Wegovy take time to work — and how long before you notice a difference?

What the STEP 1 trial actually shows about the pace of weight loss

The clearest picture of Wegovy's timeline comes from the STEP 1 trial, published in the New England Journal of Medicine, which followed adults with obesity over 68 weeks using a 2.4 mg semaglutide dose. Average weight loss at the end of the study was around 15% of body weight, but that figure accumulated gradually. The sharpest rate of loss tended to fall between weeks 16 and 36, once participants had worked through the titration schedule and settled on the maintenance dose. Before week 16, losses were real but modest.

That pattern matters for expectations. If someone starts Wegovy in January and steps on the scales in February, they are almost certainly still in the dose-escalation phase, and our page on how long Wegovy takes to work walks through what to expect at each stage of that journey. A smaller initial loss does not signal that the medicine is not working; it signals that the body is still adjusting and the dose is still climbing. The trajectory over the following months is what the evidence actually measures.

For a deeper look at the mechanism behind these changes, the how Wegovy works page covers the GLP-1 pathway in plain language.

Why the titration schedule shapes everything you feel early on

Wegovy is not taken at its full dose from day one. The schedule begins at 0.25 mg weekly, stepping up through 0.5 mg, 1.0 mg and 1.7 mg before reaching the 2.4 mg maintenance dose, each step lasting roughly four weeks, managed by your prescriber. The reason is tolerability: semaglutide slows gastric emptying and reduces appetite, and climbing too quickly tends to make the gastrointestinal side effects (nausea, loose stools, indigestion) harder to manage.

This means the medicine you are taking for the first month is genuinely a lower dose than your body will eventually settle on. Some people notice appetite changes almost immediately; others feel little in the first four weeks and then notice a meaningful shift around the six-week or ten-week mark when the dose steps up, which is something our guide on how long semaglutide takes to work covers in detail. Both patterns are normal. What a prescriber is watching is whether side effects remain manageable and whether the dose is progressing as planned, not whether the scales have moved yet.

There is practical timing here too. Someone who orders mid-month, close to a holiday, or just before a period when routine will be disrupted may want to think about when to begin the escalation steps so that dose increases happen in a settled week rather than a stressful one. Our frequently asked questions cover what to do if you miss a dose or need to pause.

When most people start to see results they can measure

The evidence from the STEP programme, alongside NHS guidance on semaglutide, points to a consistent pattern. Appetite suppression tends to be noticed within the first two to four weeks. Measurable scale changes (typically 2–5% body weight) are common by weeks eight to twelve, and if you want to understand the factors that influence that window, our page on what affects how long Wegovy takes to work goes into those variables clearly. By six months on the maintenance dose, many people in trials had reached around 10–12% average loss; the full 15% average in STEP 1 accumulated over the remaining months.

Reaching the 7.2 mg dose (approved by the MHRA in January 2026) may push results further still, trials with this higher maintenance dose reported average losses approaching 20.7% over 72 weeks. But the same principle applies: that result does not arrive in month one.

The psychological side of the journey is worth knowing about too. Many people describe a shift in their relationship with food (reduced preoccupation with eating, less urgency around hunger) that arrives before the numbers change. The psychological effects of Wegovy page explores this in more detail. Understanding that change as part of how the medicine works can make the early weeks feel less uncertain.

If you are exploring what this timeline might mean for you personally, a good starting point is our semaglutide overview, which covers eligibility, what the treatment involves, and what to expect over the course of a prescription. Eligibility for Wegovy as a prescription medicine is assessed by a prescriber on individual clinical grounds, BMI alone does not determine suitability. You can explore your options and check your eligibility through a free consultation with our clinical team.